Max Nasta-Robles - Publications

Implementation of a supervised outpatient residence to support ambulatory hematopoietic stem cell transplantation: experience from Puebla, México.

Journal: Bone marrow transplantation

Published: February 27, 2026

The actual usefulness of culturing apheresis products in hematopoietic stem cell autotransplants.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: October 15, 2025

The Number of CD34 Cells Employed in Autologous Hematopoietic Stem Cell Transplantation for Persons With Multiple Sclerosis Is Not Related to the Neurological Outcome of the Procedure.

Journal: Clinical transplantation

Published: June 23, 2025

Assessing disability in multiple sclerosis: concordance between patient-recorded and neurologist-recorded EDSS ratings in a 10-year single-center experience.

Journal: Multiple sclerosis and related disorders

Published: June 18, 2025

Predicting the response to hematopoietic stem cell transplantation in persons with multiple sclerosis: the significance of an early positive response.

Journal: Bone marrow transplantation

Published: May 13, 2025

Acute promyelocytic leukemia can be fully treated on an outpatient basis: a single institution experience.

Journal: Hematology (Amsterdam, Netherlands)

Published: October 24, 2024

Early morbimortality in autologous hematopoietic cell transplantation performed on outpatient basis in patients with autoimmune diseases: experience in 1700 patients.

Journal: Bone marrow transplantation

Published: October 14, 2024

Therapeutic Choices in Patients with Ph-Positive Chronic Myelogenous Leukemia In Mexico in the Era of Tyrosine Kinase Inhibitors: Stem Cell Transplantation or Tyrosine Kinase Inhibitors? Fifteen Years Later.

Journal: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion

Published: May 13, 2024

Prevalence and Consequences of a Delayed Diagnosis in Multiple Myeloma: A Single Institution Experience.

Journal: Clinical lymphoma, myeloma & leukemia

Published: December 06, 2023

Neutrophil to lymphocyte ratio and systemic immune-inflammatory index as markers of response to autologous hematopoietic stem cell transplantation in persons with multiple sclerosis.

Journal: International journal of laboratory hematology

Published: December 01, 2023

The consequences of delayed diagnosis and treatment in persons with multiple sclerosis given autologous hematopoietic stem cell transplantation.

Journal: Diagnosis (Berlin, Germany)

Published: November 06, 2023

In persons with CIDP, auto-HSCT can be conducted fully on an outpatient basis and induces significant clinical responses: A prospective study in a single center.

Journal: Transplant immunology

Published: August 17, 2023